Industrial real estate that houses pot production is in high demand, and is about to become the first opportunity for investors to get in on marijuana.
About $150 billion is spent on marijuana yearly. Now other countries are trying to legalize cannabis to cash in on a growing industry.
Gov. John Hickenlooper, (D-Colo.), shares his thoughts on legalized marijuana in his state.
More states are considering measures to legalize pot, and marijuana shares are up more than 180 percent this year. Here's what you should know.
Cannabis legalization is opening doors for new industries.
Goldman Sachs initiated coverage of GW Pharmaceuticals with a buy rating.
Jim Cramer spoke with the CEO of GW Pharmaceuticals following breakthrough results for its drug Epidiolex.
Cowen tells investors its favorite stocks plays for the growing legal marijuana market.
Former Minnesota independent governor Jesse Ventura backed the full legalization of weed, and Libertarian candidate Gary Johnson, in an interview.
Libertarian Party presidential nominee Gary Johnson, says he is optimistic he will get to the 15-percent needed to be part of the presidential debate. Also Johnson talks about his party's platform, including tax reform, entitlement reform, and balancing the federal budget, which would include reducing military spending. And Johnson weighs in on his stance to legalize marijuana.
Leslie Bocskor, Electrum Parnters, shares his expertise on legal marijuana, and the banking regulation problems that come with it.
CNBC's Kate Rogers reports the latest on marijuana banking regulations.
Florida's medical marijuana market launches Tuesday, but some cannabis fund managers warn of high investor risk due to the limited roll out.
A California measure to legalize marijuana use is on the state ballot for November. If passed, it would add $1.4 billion to state coffers.
CNBC's Jane Wells reports on medical marijuana for pets
CNBC's Jane Wells reports that California voters will get the chance to decide whether to legalize recreational marijuana.
Justin Gover, GW Pharmaceuticals CEO, speaks with CNBC's Meg Tirrell, about the status of regulatory filings for the Dravet syndrome drug Epidiolex and the coming launch for the medication in U.S. as well as Europe.
CNBC's Eamon Javers talks about the difficulty start-up cannabis businesses are having trying to get into the banking system. And Don Morse, Human Collective Dispensary, shows some of his Cannabis products.
The company is working with a Los Angeles-based start-up that supports the growing cannabis industry.
CNBC's Eamon Javers reports Microsoft is adding pot industry software provider "KIND Financial" to its government solutions package.